MAXIPHARMA A/S: Financial statements 2025
CVR: 87375617
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. That is a decrease of 16.5% compared with the year before. Equity in the 2025 report amounted to DKK 4,204,696. The solvency ratio was 78.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,791,625
- Profit/Loss
- DKK 434,996
- Equity
- DKK 4,204,696
- Total Assets
- DKK 5,352,772
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.8 mio. | 435 t. | 4.2 mio. | 2 |
| 2024 | - | 2.1 mio. | 411 t. | 4 mio. | 3 |
| 2023 | - | 1.8 mio. | 226 t. | 3.8 mio. | 2 |
| 2022 | - | 2 mio. | 265 t. | 3.7 mio. | 2 |
| 2021 | - | 1.7 mio. | 988 t. | 3.7 mio. | 2 |
Official annual report
How creditworthy is MAXIPHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MAXIPHARMA A/S has published its annual report for 2024. Gross profit came to DKK 2,144,691, and the net result was DKK 411,322.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.